Board Meeting6 Aug 2026, 03:31 pm
Aspira Pathlab Board Meeting on Aug 12, 2026 for Q1 Results & Fundraise
AI Summary
Aspira Pathlab & Diagnostics Ltd has announced a Board of Directors meeting scheduled for August 12, 2026. The primary agenda items include the consideration and approval of the Un-Audited Financial Results for the first quarter ended June 30, 2026. Additionally, the board will evaluate and potentially approve a proposal for raising funds through various instruments such as equity shares or warrants via preferential issue, private placements, rights issue, or other permitted methods. The company will also discuss other incidental matters. The notice of this meeting will be published on the company's website.
Key Highlights
- Board meeting scheduled for August 12, 2026.
- To consider and approve Q1 FY27 Un-Audited Financial Results.
- Proposal to raise funds via equity or warrants to be discussed.
- Fundraising methods include preferential issue and private placement.
Price Impact
More from ASPIRA